Nucleation in Amorphous Terfenadine at a Temperature Much Lower than the Glass Transition Temperature and Its Impact on Physical Stability
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Katsutoshi Yamaguchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Developability, CMC Research, Astellas Pharma Inc., 21Miyukigaoka, Tsukuba, Tsukuba, Ibaraki 3058585, Japan. Hauptthemen laut MEDLINE: Terfenadine, Glass. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Materials Science.
Abstract (Originalsprache)
In this study, the crystallization behavior of amorphous terfenadine (TFD) was investigated with a focus on nucleation temperature. The cold crystallization behavior of amorphous TFD annealed at various temperatures and the resultant crystal form were evaluated by using differential scanning calorimetry and powder X-ray diffraction. Samples annealed at -20 °C provided the lowest cold crystallization temperature and the highest proportion of form II, indicating that nucleation for form II was enhanced at a temperature much lower than the glass transition temperature (58 °C). Initiation time for isothermal crystallization of TFD at 100 °C was shortened by 30% by applying annealing at -20 °C beforehand. In contrast, dissolution and supersaturation behaviors were not affected by nucleation, as the crystal form of the precipitate was different from that induced by annealing. The isoconversional Kissinger-Akahira-Sunose model was applied to analyze the cold crystallization kinetics to find an increase in the apparent frequency factor for samples annealed at -20 °C, suggesting the presence of preformed crystal nuclei. Lastly, the anomalous nucleation behavior of amorphous TFD at low temperatures was discussed from the framework of classical nucleation theory and molecular mobility. This study provides important insights into the nucleation and crystal growth behaviors of amorphous pharmaceutical compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Developability, CMC Research, Astellas Pharma Inc., 21Miyukigaoka, Tsukuba, Tsukuba, Ibaraki 3058585, Japan.
- Analytical Research 1, Analytical Research Laboratories, CMC Development, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.
- Medical Soft Matter Group, Research Center for Macromolecules and Biomaterials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
- Graduate School of Science and Technology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.
ORCID-Profile: Katsutoshi Yamaguchi, Yuya Ishizuka, Ryo Mizoguchi, Kohsaku Kawakami
Förderung
- National Institute for Materials Science
Zitieren
APA
Yamaguchi, K., Ishizuka, Y., Yoshikawa, E., Makishima, T., Mizoguchi, R., & Kawakami, K. (2025). Nucleation in Amorphous Terfenadine at a Temperature Much Lower than the Glass Transition Temperature and Its Impact on Physical Stability. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00700
Vancouver
Yamaguchi K, Ishizuka Y, Yoshikawa E, Makishima T, Mizoguchi R, Kawakami K. Nucleation in Amorphous Terfenadine at a Temperature Much Lower than the Glass Transition Temperature and Its Impact on Physical Stability. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00700
BibTeX
@article{Yamaguchi2025,
author = {Yamaguchi, Katsutoshi and Ishizuka, Yuya and Yoshikawa, Etsushi and Makishima, Takashi and Mizoguchi, Ryo and Kawakami, Kohsaku},
title = {Nucleation in Amorphous Terfenadine at a Temperature Much Lower than the Glass Transition Temperature and Its Impact on Physical Stability},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00700}
}
EUVIMED